Alnylam Pharmaceuticals, Inc.

OXLUMO

  1. Home
  2.  / 
  3. J Code
  4.  / OXLUMO – J0224

Manufacturer:

Alnylam Pharmaceuticals, Inc.

Name:

OXLUMO

HCPCS Code Descriptor:

Injection, lumasiran, 0.5 mg

Category:

J Code

HCPCS:

J0224

NDC(s):

71336-1002-01

Primary Type:

Genetic Disorder

Generic/Specialty Status:

Single-Source

Route of Administration:

Subcutaneous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About:

OXLUMO is a Genetic Disorder drug manufactured by Alnylam Pharmaceuticals, Inc. and administered via the Subcutaneous route of administration. The J Code: J0224 is aligned to the drug OXLUMO.

Access Pricing and More By Registering

HCPCS Added Date:

7/1/21

HCPCS Effective Date:

7/1/21

HCPCS Short Description:

Inj. lumasiran, 0.5 mg

Billing and Coding Guide:

https://www.alnylamassist.com/sites/default/files/pdfdownloads/OXLUMO-lumasiran-Billing-and-Coding-Guide-for-Physician-Offices.pdf

Patient Assistance:

https://www.alnylamassist.com/

OXLUMO - J0224